$0.45
-0.11 (-20.45%)
Open$0.56
Previous Close$0.56
Day High$0.56
Day Low$0.44
52W High$3.51
52W Low$0.44
Volume—
Avg Volume44.6K
Market Cap4.99M
P/E Ratio—
EPS$-1.05
SectorPharmaceuticals
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 197.2K | 189.7K | 1.91M |
| Net Income | -7,888,690 | -6,831,348 | 328.9K |
| Profit Margin | -4,011.7% | -3,811.2% | 17.2% |
| EBITDA | -4,730,301 | -4,323,858 | 495.2K |
| Free Cash Flow | — | — | 411.8K |
| Rev Growth | +3.9% | +3.9% | -9.8% |
| Debt/Equity | 0.27 | 0.27 | 0.19 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $948.45 | -2.72% | 36.1 | 913.24B |
| JNJ | Johnson & Johnson | $221.32 | -0.53% | 26.1 | 548.94B |
| MRK | Merck & Co. Inc. | $111.38 | -0.82% | 31.3 | 279.42B |
| PFE | Pfizer Inc. | $25.68 | -3.02% | 19.3 | 150.09B |
| BMY | Bristol-Myers Squibb Co | $56.16 | -0.16% | 17.0 | 120.08B |
| ZTS | Zoetis Inc | $82.83 | -5.13% | 21.5 | 57.37B |